Phase 4 N=170 Ibuprofen and Acetaminophen Versus Ibuprofen and Acetaminophen Plus Hydrocodone for Analgesia After Cesarean Section
Opioid Use · Pain, Postoperative
Primary: Pain Level — 12.3; 15.9 millimeters on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=50 Evaluation of Gallbladder Contractility Using Both CCK and Milk Consecutively
Abdominal Pain
Primary: Gallbladder Ejection Fraction — 15 percentage of ejection of tracer
Phase 4 N=37 Optimizing Surgical Conditions During Laparoscopic Herniotomy With Deep Neuromuscular Blockade
Laparoscopic Herniotomy
Primary: Improvement of Surgical Workspace — 0; 1; 0; 0 Participants
Phase 4 N=205 CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")
Cytomegalovirus Infection
Primary: Incidence of Cytomegalovirus (CMV) Disease. — 9; 20 participants — p=0.0396
Phase 4 N=500 Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery
Coronary Artery Bypass · Antiplatelet Agents
Primary: The Patency of Saphenous Vein Grafts — 76.5; 88.7; 82.8 percentage of patent SV grafts
Phase 4 N=48 Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes
Diabetes Mellitus, Type 2
Primary: Correlation of Plasma Levels of EPA and DHA With HbA1c Reduction — -0.414; 0.067; -0.319; 0.093 pearson's correlation coefficient
Phase 4 N=46 Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea
Rosacea
Primary: Percentage of Participants With Adverse Events (AE) and Serious Adverse Events (SAE) — 5; 0 Participants
Phase 4 N=134 Tolerance of Chlorhexidine Gluconate Vaginal Cleansing Solution
Surgical Preparation of the Vagina
Primary: Number of Participants With Vaginal or Urinary Symptoms After Surgery, Assessed by Validated Questionnaire (Modified PRO-CTCAE) — 4; 11; 8; 25 Participants
Phase 4 N=230 RNS® System LTT Study
Epilepsy
Primary: Number of Participants With Serious Adverse Events (SAE) — 177 Participants
Phase 4 N=149 A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects
Rheumatoid Arthritis · Musculoskeletal and Connective Tissue Diseases
Primary: Association Between Baseline Hand and Wrist Synovitis Rheumatoid Arthritis Magnetic Resonance Imaging Scoring System (RAMRIS) Score and Flare up to Week 40 in the…
Phase 4 N=44 Nebivolol and Endothelial Regulation of Fibrinolysis (NERF)
Prehypertension · Hypertension
Primary: Heart Rate — 64; 71; 69; 58 bpm
Phase 4 N=91 Dopamine Enhancement of Fear Extinction Learning in PTSD (1R21MH108753)
Stress Disorder, Post Traumatic
Primary: Galvanic Skin Response — .37; .29; .36 Unitless
Phase 4 N=510 Antibiotic Prophylaxis for Transrectal Prostate Biopsy
Infection
Primary: Number of Participants With Post-biopsy Infection. — 6; 3 participants — p=<0.05
Phase 4 N=5 Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years
Attention Deficit Hyperactivity Disorder
Primary: Plasma Concentrations of d- and L-amphetamine — 0; 0; 3.5; 1.1 ng/mL
Phase 4 N=401 Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study)
Chronic Obstructive Pulmonary Disease
Primary: Change From Baseline in Trough (Forced Expiratory Volume (FEV1) (Pre-dose FEV1) — 0.17; 0.18 Liter